Xcell Therapeutics Passes KOSDAQ Technology Evaluation
Xcell Therapeutics passes KOSDAQ technology evaluation…claims preliminary listing in September
“Entering the global market in earnest after listing on KOSDAQ”
Xcell Therapeutics, a company specializing in culture media for cell and gene therapy (CGT), announced today that it has passed the technology assessment for a special listing on KOSDAQ.
